JW (Cayman) Therapeutics Co. Ltd (2126.HK)
HKD 1.3
(0.0%)
HKD 1.3
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 173.85 Million | 145.7 Million | 30.79 Million | - | 5.48 Million | 215 Thousand |
| Cost of Revenue | 85.63 Million | 86.94 Million | 21.75 Million | - | - | - |
| Gross Profit | 88.21 Million | 58.75 Million | 9.04 Million | - | 5.48 Million | 215 Thousand |
| Operating Expenses | 877.82 Million | 914.63 Million | 716.97 Million | 1.66 Billion | 639.2 Million | 117.03 Million |
| Selling, General and Administrative Expenses | 117.75 Million | 370.64 Million | 372.25 Million | 244.56 Million | 72.89 Million | 20.54 Million |
| Research and Development Expenses | 413.61 Million | 407.81 Million | 414.39 Million | 225.21 Million | 136.1 Million | 75.98 Million |
| Other Expenses | 346.45 Million | -853 Thousand | -558 Thousand | - | - | -45.75 Million |
| Cost and Expenses | 963.46 Million | 1 Billion | 738.72 Million | 1.66 Billion | 639.2 Million | 117.03 Million |
| Operating Income | -789.6 Million | -697.17 Million | -771.71 Million | -467.86 Million | -203.51 Million | -112.23 Million |
| Interest Expense | 12.41 Million | 6.78 Million | 2.69 Million | - | - | 2.91 Million |
| Income Tax Expense | - | 67.41 Million | 32.77 Million | - | - | 112.53 Million |
| Earnings before Tax | -767.99 Million | -846.13 Million | -702.32 Million | -1.66 Billion | -633.25 Million | -272.61 Million |
| Net Income | -767.99 Million | -846.13 Million | -702.32 Million | -1.66 Billion | -633.25 Million | -272.61 Million |
| Earnings Per Share Basic | -1.87 | -2.06 | -1.76 | -12.61 | -9.74 | -0.72 |
| Earnings Per Share Diluted | -1.87 | -2.06 | -1.76 | -12.61 | -9.74 | -0.72 |
| Weighted Average Shares Outstanding | 411.53 Million | 410.09 Million | 399.74 Million | 131.9 Million | 65 Million | 376.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 411.53 Million | 410.09 Million | 399.74 Million | 131.9 Million | 65 Million | 376.17 Million |
| Gross Margin | 0.51 | 0.40 | 0.29 | - | 1.00 | 1.00 |
| EBIT Margin | -3.77 | -4.32 | -23.99 | - | -35.46 | -707.25 |
| Profit Margin | -4.42 | -5.81 | -22.81 | - | -115.49 | -1267.98 |
| EBITDA | -655.74 Million | -752.27 Million | -738.7 Million | -454.04 Million | -194.4 Million | -115.95 Million |
| Earnings Before Tax Margin | -4.54 | -4.78 | -25.06 | - | -37.12 | -522.01 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 86.81 Million | 86.11 Million | 173.85 Million | 87.74 Million | 145.7 Million | 79.69 Million |
| Cost of Revenue | 43.07 Million | 42.71 Million | 85.63 Million | 42.92 Million | 86.94 Million | 44.07 Million |
| Gross Profit | 43.74 Million | 43.4 Million | 88.21 Million | 44.81 Million | 58.75 Million | 35.62 Million |
| Operating Expenses | 291.25 Million | 443.09 Million | 658.61 Million | 434.73 Million | 914.63 Million | 459.55 Million |
| Selling, General and Administrative Expenses | 135.4 Million | 114.38 Million | - | 138.86 Million | - | 195.27 Million |
| Research and Development Expenses | 151 Million | 197.08 Million | - | 216.53 Million | - | 211.93 Million |
| Other Expenses | 4.84 Million | 131.62 Million | 246 Thousand | - | -853 Thousand | - |
| Cost and Expenses | 334.32 Million | 485.8 Million | 744.24 Million | 477.66 Million | 1 Billion | 503.62 Million |
| Operating Income | -247.51 Million | -399.68 Million | -789.6 Million | -308.53 Million | -697.17 Million | -356.3 Million |
| Interest Expense | - | - | 12.41 Million | - | 6.78 Million | - |
| Income Tax Expense | 6.99 Million | 138.07 Million | -3.29 Million | - | 67.41 Million | - |
| Earnings before Tax | -240.26 Million | -387.58 Million | -767.99 Million | -380.41 Million | -846.13 Million | -416.88 Million |
| Net Income | -240.26 Million | -387.58 Million | -767.99 Million | -380.41 Million | -846.13 Million | -416.88 Million |
| Earnings Per Share Basic | -0.58 | -0.94 | - | -0.93 | - | -1.01 |
| Earnings Per Share Diluted | -0.58 | -0.94 | - | -0.93 | - | -1.01 |
| Weighted Average Shares Outstanding | 413.08 Million | 411.93 Million | 411.53 Million | 411.12 Million | 410.09 Million | 411.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 413.08 Million | 411.93 Million | 411.53 Million | 411.12 Million | 410.09 Million | 411.8 Million |
| Gross Margin | 0.50 | 0.50 | 0.51 | 0.51 | 0.40 | 0.45 |
| EBIT Margin | -2.36 | -2.62 | - | -3.05 | - | -4.06 |
| Profit Margin | -2.77 | -4.50 | -4.42 | -4.34 | -5.81 | -5.23 |
| EBITDA | -204.92 Million | -225.47 Million | - | -267.21 Million | - | -323.79 Million |
| Earnings Before Tax Margin | -2.85 | -4.64 | -4.54 | -3.52 | -4.78 | -4.47 |
ENMHF
603897
EXICOM
TWCI
AHL-PC
NTAC